Lee E, et al. - Herein, researchers reported their experience of managing children with primary hyperoxaluria type-1 (PH-1) and end-stage renal disease (ESRD) on hemodialysis (HD) who underwent combined liver–kidney transplant (CLKT) at their institution from 2005 to 2015. CLKT continued to be the definitive treatment for PH-1, while bilateral native nephrectomy at the time of transplant was shown to be effective at attenuating postoperative oxalate stores and may mitigate damage to the renal allograft.